Introduction: Medical Imaging AI Is the Most Mature Clinical AI Application

Medical imaging is where clinical AI has the deepest track record. Unlike other workflow stages where AI adoption is still in early phases, imaging AI has FDA-cleared algorithms in production at thousands of hospitals, peer-reviewed validation across multiple modalities, and established integration pathways through DICOM and DICOMweb standards. Over 800 AI-enabled medical devices have received FDA clearance, with radiology and cardiology leading the count.

For clinical research specifically, imaging AI addresses several critical bottlenecks: automated measurements for trial endpoints (like RECIST tumor measurements), quality assurance on imaging protocols across multi-site trials, accelerated image reading workflows, and quantitative analysis that would be impractical manually. A radiologist reading a lung CT for a clinical trial endpoint might spend 20–30 minutes on detailed measurements and annotations; AI can perform the same quantitative analysis in seconds, with reproducibility that eliminates inter-reader variability.

In 2026, the maturity of imaging AI means the question isn’t whether to use it — it’s which tools to integrate and how to build a stack that handles the DICOM data pipeline, AI inference, and results reporting in a way that’s compliant with both clinical trial regulations and radiology workflows.

The Imaging AI Problem: What AI Is Actually Solving

Automated measurements and endpoints. Clinical trials in oncology, pulmonology, and neurology rely on imaging-based endpoints — tumor measurements (RECIST), brain volume changes (volumetrics), lung function indicators (quantitative CT). Manual measurement is time-consuming, subjective, and prone to inter-reader variability. AI provides consistent, reproducible measurements that reduce variability and accelerate endpoint evaluation.

Image quality assurance. Multi-site trials often struggle with inconsistent imaging protocols — different scanners, different acquisition parameters, different reconstruction kernels. AI-powered QA can flag non-compliant images at the point of acquisition, before they enter the analysis pipeline.

Accelerated reads. Central imaging review for trials can create bottlenecks when large volumes of studies arrive simultaneously. AI pre-processing — identifying normal studies, flagging critical findings, performing preliminary measurements — helps radiologists prioritize and accelerate their reads.

Quantitative analysis. AI enables analyses that are impractical manually: whole-lung density mapping, vessel segmentation, texture analysis, and longitudinal change quantification across time points. These quantitative biomarkers can serve as secondary endpoints or enrichment criteria.

DICOM/DICOMweb integration. The technical challenge in imaging AI is the data pipeline — getting images from clinical sites to central analysis, running AI inference, and returning results to the trial database. DICOM and DICOMweb standards are the backbone, but integration requires careful pipeline design.

The Recommended Medical Imaging AI Stack

Layer 1: AI Framework and Model Development

Primary recommendation: MONAI (Medical Open Network for Artificial Intelligence)

MONAI is the leading open-source framework for medical imaging AI, developed by NVIDIA and King’s College London. Built on PyTorch, MONAI provides pre-built components for medical image analysis: data loading, preprocessing, augmentation, model architectures, loss functions, and metrics — all specifically designed for 3D medical imaging data.

For clinical research teams, MONAI’s value is in enabling custom AI development tailored to trial-specific imaging endpoints. If your trial needs a quantitative biomarker that no commercial product provides — a specific vessel measurement in lung CT, a novel texture feature in liver MRI, a volumetric analysis in brain imaging — MONAI gives you the building blocks.

MONAI Deploy provides a pathway from model development to clinical deployment, with DICOM input/output handling, Kubernetes orchestration, and compliance-ready packaging.

When to use MONAI vs. commercial tools: Use MONAI when you need custom imaging biomarkers, novel quantitative endpoints, or research-grade analysis not available in commercial platforms. Use commercial tools (below) when you need FDA-cleared algorithms for standard clinical endpoints.

Layer 2: Clinical Imaging AI Platforms

Primary recommendation: Aidoc

Aidoc provides FDA-cleared AI solutions for radiology workflow optimization. Its algorithms cover multiple modalities and findings: pulmonary embolism detection on CT angiography, intracranial hemorrhage on head CT, cervical spine fractures, aortic emergencies, and incidental pulmonary nodule detection on chest CT. For clinical trials, Aidoc’s triage and flagging capabilities accelerate central image review workflows.

Aidoc integrates directly into PACS environments via DICOM, requiring minimal IT infrastructure changes. Results appear as notifications within the radiologist’s existing reading workflow rather than requiring a separate platform.

Alternative: Viz.ai — Specializes in large vessel occlusion (LVO) stroke detection and cardiovascular imaging AI. FDA-cleared algorithms with direct notification to specialists. Best for trials in neurology and cardiology where time-to-detection is a trial outcome measure.

Alternative: Annalise.ai — Broad-spectrum chest X-ray AI that detects 124+ findings simultaneously. Useful for trials requiring comprehensive chest imaging screening where the volume of reads would otherwise create bottlenecks.

Layer 3: DICOM Infrastructure and Imaging Data Pipeline

Primary recommendation: Orthanc + DICOMweb

Orthanc is the leading open-source DICOM server, providing a lightweight, standards-compliant imaging data hub. For clinical research, Orthanc handles the critical data pipeline functions: receiving images from trial sites (DICOM C-STORE), routing images to AI analysis engines, storing results, and exposing data via DICOMweb REST APIs for integration with EDC and trial management systems.

Combined with DICOMweb (the HTTP/REST-based standard for DICOM), Orthanc enables cloud-native imaging workflows where images flow from site PACS to central analysis and back without the legacy networking constraints of traditional DICOM.

Alternative: Google Cloud Healthcare API — Provides managed DICOM storage and DICOMweb endpoints in Google Cloud. Best for organizations running cloud-native trial infrastructure and wanting to avoid managing their own DICOM servers.

Alternative: OHIF Viewer — Open-source web-based DICOM viewer that pairs with Orthanc for browser-based image review. Useful for remote central reading workflows where reviewers need web access to trial imaging without a local PACS installation.

Tool Comparison Matrix

Implementation Guide

Step 1: Define Your Imaging Endpoints

Before selecting tools, define exactly what imaging analysis your trial requires. Standard RECIST measurements? Quantitative lung density? Novel biomarkers? This determines whether you need commercial FDA-cleared tools (Aidoc, Viz.ai) or custom models (MONAI).

Step 2: Build Your DICOM Pipeline

Deploy Orthanc as your central imaging hub. Configure DICOM routing rules to receive images from trial sites, route them to AI analysis engines, and store results. If running in the cloud, consider Google Healthcare API for managed DICOMweb endpoints.

Step 3: Integrate AI Analysis

For standard clinical findings (PE detection, hemorrhage triage), deploy Aidoc at your central reading site. For custom quantitative endpoints, develop models using MONAI and deploy them via MONAI Deploy alongside your Orthanc infrastructure.

Step 4: Connect to Your Trial Data Pipeline

Imaging results need to flow into your EDC system. Use DICOMweb APIs to export AI measurements and link them to patient records in your clinical database. Make.com can orchestrate the handoff — triggering when new AI results are available and pushing structured data to your EDC via API.

Step 5: Quality Assurance

Implement AI-powered image QA at the point of acquisition. Flag non-compliant imaging protocols (wrong slice thickness, missing sequences, incorrect contrast timing) before the images enter the analysis pipeline.

ROI and Evidence

• AI-assisted measurements reduce inter-reader variability by 40–60% for standard imaging endpoints like RECIST
• Automated triage accelerates central reading workflows by prioritizing critical findings
• MONAI-based custom models enable novel quantitative biomarkers that would be impractical with manual analysis
• DICOMweb-based pipelines eliminate the networking bottlenecks of legacy DICOM, enabling cloud-native imaging workflows
• AI QA at acquisition prevents downstream analysis failures from non-compliant imaging — avoiding costly re-imaging visits

What’s Next in This Series

1. Protocol Design and Simulation
2. Patient Recruitment and Matching
3. Clinical Data Management
4. Safety Monitoring and Pharmacovigilance
5. Medical Imaging AI ← You are here
6. Regulatory Submissions — Next
7. Clinical Documentation and Scribing

Return to the Complete AI Stack for Clinical Research | View all AI Healthcare Stacks

Published on EmergingAIHub.com | AI Workflow Intelligence for Healthcare Professionals
Last updated: March 2026

Key tools covered

MONAI, Aidoc, Viz.ai, Annalise.ai

Navigate the Clinical Research AI Stack Series

← Return to The Complete AI Stack for Clinical Research

Previous: Safety Monitoring AI Stack

Next: Regulatory Submissions AI Stack

View all AI Healthcare Stacks